Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.2c01523 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Yijia Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Joint Research Institution of Altitude Health, Department of Respiratory and Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Ce…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 198 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China, West China Hospital, Sichuan University.
Abstract (Originalsprache)
CK2 (casein kinase 2) is a serine/threonine protein kinase that is ubiquitous in eukaryotic cells and plays important roles in a variety of cellular functions, including cell growth, apoptosis, circadian rhythms, DNA damage repair, transcription, and translation. CK2 is involved in cancer pathogenesis and the occurrence of many diseases. Therefore, targeting CK2 is a promising therapeutic strategy. Although many CK2-specific small-molecule inhibitors have been developed, only CX-4945 has progressed to clinical trials. In recent years, novel CK2 inhibitors have gradually become a research hotspot, which is expected to overcome the limitations of traditional inhibitors. Herein, we summarize the structure, biological functions, and disease relevance of CK2 and emphatically analyze the structure-activity relationship (SAR) and binding modes of small-molecule CK2 inhibitors. We also discuss the latest progress of novel strategies, providing insights into new drugs targeting CK2 for clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Joint Research Institution of Altitude Health, Department of Respiratory and Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hos…
- College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, China.
- Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, Chi…
- Tianfu Jincheng Laboratory, Chengdu, Sichuan 610041, China.
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
- West China School of Stomatology Sichuan University, Chengdu, Sichuan 610064, China.
ORCID-Profile: Yuxi Wang, Jifa Zhang
Förderung
- Natural Science Foundation of Sichuan Province
- National Natural Science Foundation of China
- West China Hospital, Sichuan University
Zitieren
APA
Chen, Y., Wang, Y., Wang, J., Zhou, Z., Cao, S., & Zhang, J. (2023). Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01523
Vancouver
Chen Y, Wang Y, Wang J, Zhou Z, Cao S, Zhang J. Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01523
BibTeX
@article{Chen2023,
author = {Chen, Yijia and Wang, Yuxi and Wang, Jiaxing and Zhou, Zhilan and Cao, Shu and Zhang, Jifa},
title = {Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.2c01523}
}
EUVIMED